Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
KPV (molecular weight: 384.48 g/mol) is derived from the C-terminal end of -MSH and has been investigated in models of intestinal and airway inflammation, as well as epithelial barrier function
In the control group of rats, obstruction of the superior mesenteric vein was also observed, where peripheral and central thrombosis quickly appeared
In summary: BPC-157 is a promising compound for different cytoprotective uses It is not FDA approved for human use There is not some shadow cabal blocking the use of BPC-157 - Financial incentives make it so that BPC-157 is challenging to push through the regulatory process - It will likely never receive FDA approval, but will be available in some form as oral supplement or through compounding pharmacies, with some modification This is not medical advice
Copyright 2015
doi: 10.1016/j.amepre.2015.02.009
Existing patients Choose your protocol below
US$ 20.22
US$ 26.36
US$ 23.85
US$ 21.22
US$ 20.45
US$ 25.62
US$ 25.51
US$ 23.65